Coronavirus Covid-19 Testing: Symptoms, Asymptomatic, and Serology for Immunity

$1950 - Single Copy or $3900 - Web Posting | Report # SH28421314 | 103 Pages | 20 Tables and Figures | 2020
  • Key Topics
  • Coronavirus
  • Covid-19
  • SARS Testing
  • Patient Testing 2020
  • Symptoms Testing
  • Asymptomatic Testing
  • Serology for Testing Immunity

LEXINGTON, Massachusetts (April 3, 2020) – WinterGreen Research announces that it has a new study available that describes United States testing for the rapidly evolving COVID-19 pandemic.  Testing capability forecasts for PCR assay and Molecular Diagnostics are presented in two week increments for the next 6 months.  Availability of Serological testing is also forecast for detection of the virus after recovery.  All major vendors are included and can be compared with quantities, qualities, and test time.

Covid-19 Testing 2020: The Way Forward describes the timelines the virus is likely to take regarding quarantines and successive waves of infection.  Successive waves of infection are expected to strike the US population after the shelter in place restrictions start to be lifted.  Intensive testing is needed at every stage of covid-19 disease management.  The testing scenarios and the vendors with good test kits are described in detail.

Successive waves of infection are expected to continue to at least January 2021.  One thing that  will stop them is if effective vaccine is found.  The 2020 study has 96 pages, 12 tables and figures.    The tables describe in enormous detail what testing kits are available and the significance of further testing.   It describes testing capacity and length of time to administer testing.  It describes the impact of testing and the need for serological testing as the quarantines begin to end.
PCR testing – as used by the CDC and WHO initially – is very labor intensive, and has several points along the path of doing a single test where errors may occur – which may lead to headline issues of a false positive, the test showing evidence of the virus when it’s not actually there, or a false negative, suggesting someone doesn’t have the virus when in fact they do.  

The virus and the resulting disease, Covid-19, have hit Germany with force:  According to Johns Hopkins University, the country had more than 91,000 laboratory-confirmed infections by Saturday morning, more than any other country except the United States, Italy and Spain.  But with 1,275 deaths, Germany’s fatality rate stood at 1.3 percent, compared with 12 percent in Italy, around 10 percent in Spain, France and Britain, 4 percent in China and 2.5 percent in the United States. Even South Korea, a model of flattening the curve, has a higher fatality rate, 1.7 percent.

When the first cases of COVID-19 were reported in the US, two labs at the CDC were the only ones permitted to conduct COVID-19 testing, using a test developed by the agency’s own researchers. When the CDC tried to expand testing by providing its test kits to state and local public health labs, there were problems with the initial version of the kits,  The CDC, despite initially faulty reagents making its first test kits unreliable, is now offering accurate RT-PCR Diagnostic Panels and positive and human specimen controls.

“Had {the US} done more testing from the very beginning and caught cases earlier,” said Dr. Nuzzo, of Johns Hopkins, “we would be in a far different place.”
WinterGreen Research is an independent research organization funded by the sale of market research studies all over the world and by identifying next generation technology.  It is next generation technology that drives market growth.  The company has 35 distributors worldwide, including Global Information Info Shop, Market, Research and Markets, Report Linker

WinterGreen Research is positioned to help customers facing challenges that define the modern enterprises. The increasingly global nature of science, technology and engineering is a reflection of the implementation of the globally integrated enterprise.  

Customers trust WinterGreen Research to work alongside them to ensure the success of the participation in a particular market segment.
WinterGreen Research supports various market segment programs; provides trusted technical services to the marketing departments.  It carries out accurate market share and forecast analysis services for a range of commercial and government customers globally.  These are all vital market research support solutions requiring trust and integrity.


Companies Profiled
Market Leaders
  • Abbott Labs Leverages ID Now Platform w/ Installed Base of 15,000
  • Abbott Labs M2000
  • Thermo Fisher Scientific
  • CDC
  • bioMérieux
  • Danaher / Cepheid
  • Danaher / IDT
  • LabCorp
  • Quest Diagnostics
  • Roche
  • SunSure Biotech
  • OPKO / BioReference Laboratories
  • Hologic
  • Mammoth
  • Other - 260 Companies

Report Methodology

This is the 842nd report in a series of market research reports that provide forecasts in communications, telecommunications, the internet, computer, software, and telephone equipment. The project leaders take direct responsibility for writing and preparing each report. They have significant experience preparing industry studies. Forecasts are based on primary research and proprietary databases. Forecasts reflect analysis of the market trends in the segment and related segments. Unit and dollar shipments are analyzed through consideration of dollar volume of each market participation in the segment. Market share analysis includes conversations with key customers of products, industry segment leaders, marketing directors, distributors, leading market participants, and companies seeking to develop measurable market share. Over 200 in-depth interviews are conducted for each report with a broad range of key participants and opinion leaders in the market segment.

About the Company

WinterGreen Research, founded in 1985, provides strategic market assessments in telecommunications, communications equipment, health care, and advanced computer technology. Industry reports focus on opportunities that will expand existing markets or develop major new markets. The reports assess new product and service positioning strategies, new and evolving technologies, and technological impact on products, services, and markets. Market shares are provided. Leading market participants are profiled, and their marketing strategies, acquisitions, and strategic alliances are discussed. The principals of WinterGreen Research have been involved in analysis and forecasting of international business opportunities in telecommunications and advanced computer technology markets for over 30 years.

About the Principal Author

Susan Eustis, President, co-founder of WinterGreen Research, has done research in communications and computer markets and applications. She holds several patents in microcomputing and parallel processing. She is the author of recent studies of the Service Oriented Architecture (SOA) marketing strategies, Internet software, a study of Push to Talk Equipment, Worldwide Telecommunications Equipment, Top Ten Telecommunications, Digital Loop Carrier, Web Hosting, Business Process Management, Servers, Blades, the Mainframe as a Green Machine, and Application Server markets. Ms. Eustis is a graduate of Barnard College.

$1950 - Single Copy or $3900 - Web Posting | Report # SH28421314 | 103 Pages | 20 Tables and Figures | 2020